Bio-Rad Laboratories, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 86   

Articles published

BIO 141.64 +1.59 (1.14%)
price chart
Bio-Rad Laboratories, Inc. Short Interest Update
Bio-Rad Laboratories, Inc. (NYSE:BIO) stated loss of 1,647 shares or 0.2% in the short interest. The short interest registered from 1,078,366 on October 30,2015 to 1,076,719 on November 13,2015.
Bio-Rad Laboratories Sees Unusually-High Trading Volume (BIO)  Putnam Standard
Will Bio Rad Laboratories Class A (NYSE:BIO) be able to hit Analyst ...  The Bulletin
Is Smart Money Gaining Confidence In Bio-Rad Laboratories, Inc. (BIO)?
There were 25 hedge funds in our database with Bio-Rad Laboratories, Inc. (NYSE:BIO) positions at the end of the previous quarter.
Bio Rad Laboratories Inc (BIO) Files Form 4 Insider Selling : Giovanni Magni ...
Bio Rad Laboratories Inc (BIO): Giovanni Magni , EVP, Chief Strategy Officer of Bio Rad Laboratories Inc sold 6,000 shares on Nov 18, 2015.
Bio-Rad Laboratories (BIO) – Research Analysts' Recent Ratings Updates  Voice Chronicle
Bio Rad Laboratories Inc (BIO) Files Form 4 Insider Selling : Michael Crowley ...
Bio Rad Laboratories Inc (BIO): Michael Crowley , EVP, GBL Commercial Operations of Bio Rad Laboratories Inc sold 549 shares on Nov 13, 2015.
Brokerages Expect Bio-Rad Laboratories to Announce $1.27 Earnings Per Share ...  Dakota Financial News
Bio Rad Laboratories Inc (NYSE:BIO) Sentiment Increased in Q2 2015
Bio Rad Laboratories Inc (NYSE:BIO) hedge funds sentiment decreased to 1.13 in Q2 2015. Its down -0.21, from 1.34 in 2015Q1.
Bio-Rad Laboratories Cut to Hold at Zacks (BIO)  Voice Chronicle
Bio-Rad Laboratories (BIO) to Release Earnings on Tuesday  Dakota Financial News
Company Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) Rally 2.34%
Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) appreciated by 2.34% during the past week but lost 1.12% on a 4-week basis.
Bio-Rad Laboratories, Inc. (NYSE:BIO.B)'s EVP – Chief Strategy Officer ...
Bio Rad Laboratories Class A shares (NYSE:BIO) change +0.15%vs previous 50 days  The Bulletin
Bio-Rad Laboratories Inc (NYSE:BIO) close to 52-week high, short interest down
Bio-Rad Laboratories Inc (NYSE:BIO) (TREND ANALYSIS) shares were traded with thin volume. The stock closed last trading session at $144.71, down by -2.98%, with a volume of 112,575 shares against an average volume for the last 3 months of 139,391.
Company Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) Drops by -0.94%
Bio-Rad Laboratories, Inc. (NYSE:BIO) has dropped 0.94% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 1.65% in the last 4 weeks.
Bio-Rad Laboratories, Inc. (NYSE:BIO) Expected to Report $0.53 Per Share  Investor Newswire
Bio-Rad Labs (BIO) Announces Quarterly Earnings Results, Beats Expectations ...  Money Flow Index
Company Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) Drops by -2.21%
Bio-Rad Laboratories, Inc. (NYSE:BIO) has lost 2.21% during the past week and dropped 8.32% in the last 4 weeks. The shares have outperformed the S&P 500 by 1.23% in the past week but underperformed the index by 0.86% in the last 4 weeks.
Investor Investigation of Bio-Rad Laboratories, Inc. (NYSE:BIO) over possible ...
An investigation on behalf of investors of Bio-Rad Laboratories, Inc. (NYSE:BIO) shares over potential securities laws violations by Bio-Rad Laboratories and certain of its directors and officers in connection certain financial statements was announced.